Coronavirus information

Visitor restrictions, information for patients and more.

View coronavirus information

FOI 0327 2019/20: Chimeric Antigen Receptor T-Cell (CAR- T-cell) Therapies

Freedom of Information Request: 0327 2019/20

I would like to make a Freedom of Information request with regards to the usage of Chimeric Antigen Receptor T-Cell (CAR T-cell) therapies. Could you please provide me with the following numbers of patients treated in the last 12 months (latest 12 months possible) with the following drugs and where possible please could you split by the indication for which the drug was provided:

Number of patients treated B-cell acute lymphoblastic leukaemia (ALL) Relapsed or refractory diffuse large B-cell lymphoma (DLBCL) Primary mediastinal large B-cell lymphoma (PMBCL) All Indications


Yescarta (axicabtagene ciloleucel) Not Applicable * * *
Kymriah (tisagenlecleucel) * * * *

Where the number of patients treated is less than 6 (six) please could you redact this amount by replacing with an asterisk (“*”)

Thinking of going to Accident and Emergency but not sure if you need to? Try our handy symptom checker.

Try ask A&E

We're improving the accessibility of our websites. If you can't access any content or if you would like to request information in another format, please view our accessibility statement.